NIH-funded research U01 cooperative agreement

Endoscopic treatment versus shunt for hydrocephalus in infants

Official title: Endoscopic versus Shunt Treatment of Hydrocephalus in Infants

Funded at Utah State Higher Education System--University of Utah · NIH-11608584 · Data updated 2026-11-12

This project tests whether a shunt-free endoscopic procedure can be as good as traditional shunting for babies with hydrocephalus.

More Hydrocephalus research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2027
Funding year2026
Award (this year)$47,915
NIH project number3U01NS107486-07S2
Project IDNIH-11608584 on NIH RePORTER

Who could benefit from this research

Could help

Infants ≤12 months corrected age with hydrocephalus treated at participating tertiary pediatric neurosurgery centers in North America.

Less likely to help

Infants for whom ETV+CPC is not appropriate or who are not candidates for either procedure.

What this research studies

Infants with hydrocephalus often need a cerebrospinal fluid shunt, but shunts have lifelong complications and high costs. This study compares endoscopic third ventriculostomy with choroid plexus cauterization (ETV+CPC) to shunt placement in babies up to 12 months old, focusing on cognitive outcomes 12 months after surgery. It uses Bayley scales to measure development and aims to show non-inferiority of ETV+CPC so families can consider shunt-free options. The research is conducted at major pediatric neurosurgery centers in North America, led by the University of Utah. If successful, findings could influence standard care and reduce long-term shunt-related issues for infants.

Why it matters

Potential benefit: If ETV+CPC is non-inferior cognitively, more infants could avoid shunts and their lifelong complications.

How similar studies have gone: Preliminary data suggest ETV+CPC can be safe and viable, but cognitive outcomes compared with shunt require confirmation.

Where this research is happening

  • Utah State Higher Education System--University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Kestle, John — Utah State Higher Education System--University of Utah
  • Study coordinator: Kestle, John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.